ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
ILIAS Biologics announces the 2nd POC study, showing anti-inflammatory effects of ILB202 on preterm birth
February 02, 2021ILIAS Biologics, Inc. announced that its latest research in collaboration with researchers at The University of Texas Medical Brand at Galveston (UTMB) is published in the journal Science Advances. -
An in vitro study shows Pfizer-BioNTech COVID-19 vaccine elicits antibodies that neutralize SARS-CoV-2 with a mutation associated with rapid transmission
January 11, 2021Pfizer Inc. and BioNTech SE announced results from an in vitro study conducted by Pfizer and the University of Texas Medical Branch (UTMB) that shows the antibodies from people who have received the Pfizer-BioNTech COVID-19 vaccine effectively ... -
Moleculin, UTMB partner to study WP1122 for coronavirus
March 19, 2020Moleculin Biotech has partnered with the University of Texas Medical Branch at Galveston (UTMB) to test its molecular inhibitors, including WP1122, to treat different viruses ... -
Moleculin, UTMB Evaluate Inhibitors for Antiviral Properties
March 18, 2020Moleculin will supply the lead drug candidate, WP1122, and related inhibitors, as well as technical support.
Pharma Sources Insight January 2025
